Applications Published 12 December 2001

Published: 1-Sep-2002

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).

  • Method for making pharmaceutical tablets by compression
    Talc de Luzenac 1161218*

  • Method for producing cosmetic or pharmaceutical formulations by means of a micromixture directly before use
    Merck 1161221*

  • Method of treating hair loss using non-immunosuppressive compounds
    University of Texas Southwestern Medical Centre 1161222*

  • Metered dose inhalers with isobutane as propellant
    IG Spruehtechnik 1161225*

  • Phospholine linked prodrug derivatives
    SuperGen 1161226*

  • Microparticles for the delivery of nucleic acid
    Zycos 1161227*

  • Compsn comprising isoquercetin and ascorbic acid in a sustained release form
    Merck 1161228*

  • Method for preventing crystal growth and particulate aggregation in nanoparticulate compsns
    Elan Pharma 1161229*

  • Transdermal therapy system and method for producing the same LTS Lohmann
    Therapie-Systeme 1161230*

  • Method of inhibiting a chaperone protein
    The United States of America, as represented by the Secretary, Dept of Health and Human Services 1161231*

  • Hydroxy diphenyl urea sulphonamides as IL-8 receptor antagonists
    SmithKline Beecham 1161232*

  • LXR modulators
    Tularik 1161233*

  • Method for delivering benzidine prostaglandins by inhalation
    United Therapeutics Corp 1161234*

  • Combinations for the treatment of diseases involving angiogenesis
    Angiogene Pharmaceuticals 1161235*

  • Dihydroxy open-acid and salts of HMG-CoA reductase inhibitors
    Merck 1161236*

  • Protease inhibitors
    SmithKline Beecham 1161237*

  • Amyotropic lateral sclerosis treatment with a combination of riluzole and an AMPA receptor antagonist
    Aventis Pharma 1161238*

  • 3-cyclopropylemthoxy-4-difluoromethoxy-N-(3,5-dichloropyrid-4-yl)benxamide in the treatment of multiple sclerosis Byk Gulden Lomberg Chemische
    Fabrik 1161239*

  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Du Pont Pharmaceuticals 1161240*

  • Stable pharmaceutical application form for paroxetin anhydrate
    RP Scherer; Knoll 1161241*

  • Compsn and method for treating diabetes
    Beyer, Camille 1161242*

  • Pharmaceutical compsns comprising a pyrimidine derivative and cyclodextrin
    Knoll 1161243*

  • Use of 1,2,4-triazolo(1m5-A)pyrimidine derivatives for treating migraine
    Knoll 1161244*

  • Method and compsn for prevention of scar formation in glaucoma filtration bleb and drainage fistula
    Synphora 1161245*

  • Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogues thereof
    Inspire Pharmaceuticals 1161246*

  • Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolised antibiotic
    Pathogenesis Corp 1161247*

  • Pharmaceutical compsn containing nitrate source and an acidifying agent for treating skin ischaemia Queen Mary and Westfield
    College 1161248*

  • Immunostimulant bacterial membrane fractions in cancer treatment
    Pierre Fabre Medicament 1161250*

  • Use of a compsn containing Klebsiella pneumoniae proteoglycans, and bacterial ribosomes or ribosomal RNAs for treating and/or preventing periodontal diseases
    Pierre Fabre Sante 1161251*

  • Use of extracts from Gingko bilboa for treating sleep disorders
    Medichemie 1161252*

  • Use of hop flowers for medicinal treatments
    van Eijsselstein, Danny; van Eeuwijk, Wouter 1162253*

  • Treatment of autoimmune diseases with American ginseng extract
    CV Technologies 1161254*

  • Methods and compsns for treating erectile dysfunction
    Merck 1161255*

  • Use of nerve growth factor for therapy of intraocular tissue pathologies
    Anabasis 1161256*

  • Pharmaceutical compsns containing TGF-beta
    Novartis 1161257*

  • Compsns and methods for use of LDL-like receptor ligands for the treatment of cancer and angiogenic-based disease
    EntreMed 1161258*

  • Intranasal delivery of Pneumococcal polysaccharide vaccines
    Aventis Pasteur 1161259*

  • Tumour necrosis factor antagonists for the treatment of neurological disorders
    Tobinick, Edward; Tobinik, Arthur Jerome 1161260*

  • Apoptosis inducing molecule and methods of use
    Human Genome Sciences; Ebner, Richard; Yu, Guo-Liang; Zhai, Yifan; Ullrich, Stephen 1161261*

  • Analgesic compsns comprising anti-epileptic compounds and methods of using same
    Warner-Lambert 1161263*

  • Polymer compsns for polynucleotide delivery
    West Pharmaceutical Services Drug Delivery & Clinical Research Centre 1161264*
  • You may also like